What should you know about GATA3 immunohistochemistry pathology outlines?

A pathologist applies an antibody stain to tissue taken during a biopsy. If tumour cells show staining, the result is called GATA3 positive; if they do not, it is GATA3 negative. The result is a clue, not a diagnosis by itself. GATA3 can be seen in several tumour types, including many breast and urothelial tumours, so the finding must be read with the cell appearance, location, imaging, and other stains.

Read the GATA3 result together with the full pathology impression. Ask which tumour origins the staining supports, whether the pattern is diffuse or limited, and which additional markers were used to narrow the possibilities. A pathology report may also describe staining intensity and the percentage of cells that stain; these details can affect interpretation. Your oncology team can connect the laboratory findings with scans and treatment planning.

Contact the clinician who ordered the biopsy if the report is unclear, the sample is described as inadequate, or the recommended follow-up is not explained. Seek urgent medical help for heavy bleeding, worsening shortness of breath, severe pain, confusion, or sudden weakness after a procedure; these symptoms need assessment regardless of the GATA3 result.

Which cells stained for GATA3, and what tumour origins remain possible? What other stains or tests are needed? Does this result change the diagnosis, staging work-up, or treatment discussion?